Cost-Effectiveness of HIV Treatment in Resource-Poor Settings — The Case of Côte d'Ivoire

Abstract

A strategy of trimethoprim-sulfamethoxazole prophylaxis and antiretroviral therapy, with the use of clinical criteria alone or in combination with CD4 testing to guide the timing of treatment, is an economically attractive health investment in settings with limited resources.